Cost-effectiveness of oral anticancer drugs and associated individualised dosing approaches in patients with cancer: protocol for a systematic review

INTRODUCTION: Oral anticancer drugs (OADs) have rapidly expanded with more than 70 OADs targeting several molecular targets. Many of the OADs exert an exposure–response relationship but still, a ‘one-size fits-all’ dose is used, ignoring interindividual variability. Several of these OADs share simil...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dyk, Madelé, Bulamu, Norma, Boylan, Chelsea, Mc Laughlin, Anna M, Kichenadasse, Ganessan, May, Nikki, Michelet, Robin, Kloft, Charlotte, Kaambwa, Billingsley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Health Economics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372804/
https://www.ncbi.nlm.nih.gov/pubmed/34404700
http://dx.doi.org/10.1136/bmjopen-2020-047173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372804/
https://www.ncbi.nlm.nih.gov/pubmed/34404700
http://dx.doi.org/10.1136/bmjopen-2020-047173

Ejemplares similares